Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cardiac hypertrophy is induced by a number of stimuli and can lead to cardiomyopathy and heart failure. Cardiomyocyte hypertrophy is characterized by increased cell size and altered gene expression. By differential-display polymerase chain reaction and Western blotting we found that the transcriptional coactivator
MBF1
was upregulated during hypertrophy in cardiomyocyte cultures. Furthermore,
MBF1
protein level increased in two animal models of hypertrophy, angiotensin II treatment and aortic banding.
MBF1
antisense oligodeoxynuclotides blocked phenylephrine-induced hypertrophy, suggesting
MBF1
plays a key role in hypertrophic growth. In contrast, overexpression of
MBF1
potentiated the hormone-induced response of the atrial natriuretic peptide promoter.
MBF1
overexpressed by transient transfection cooperated with the transcription factor
c-Jun
in activation of transcription but not with GATA4.
MBF1
and
c-Jun
induced the activity of a transiently transfected atrial natriuretic peptide promoter, whereas neither
MBF1
nor
c-Jun
could induce the promoter alone. Moreover,
MBF1
bound to
c-Jun
in vitro. These data suggest that
MBF1
is a transcriptional coactivator of
c-Jun
regulating hypertrophic gene expression. Inhibitor studies suggested that
MBF1
activates the atrial natriuretic peptide promoter independently of the calcineurin and CaMK signaling pathways. Our results indicate that
MBF1
participates in hormone-induced cardiomyocyte hypertrophy and activates hypertrophic gene expression as a coactivator of
c-Jun
.
...
PMID:Multiprotein bridging factor 1 cooperates with c-Jun and is necessary for cardiac hypertrophy in vitro. 1272 99
Basic leucine zipper proteins Jun and Fos form the dimeric
transcription factor AP-1
, essential for cell differentiation and immune and antioxidant defenses. AP-1 activity is controlled, in part, by the redox state of critical cysteine residues within the basic regions of Jun and Fos. Mutation of these cysteines contributes to oncogenic potential of Jun and Fos. How cells maintain the redox-dependent AP-1 activity at favorable levels is not known. We show that the conserved coactivator
MBF1
is a positive modulator of AP-1. Via a direct interaction with the basic region of Drosophila Jun (D-Jun),
MBF1
prevents an oxidative modification (S-cystenyl cystenylation) of the critical cysteine and stimulates AP-1 binding to DNA. Cytoplasmic
MBF1
translocates to the nucleus together with a transfected D-Jun protein, suggesting that
MBF1
protects nascent D-Jun also in Drosophila cells. mbf1-null mutants live shorter than mbf1+ controls in the presence of hydrogen peroxide (H2O2). An AP-1-dependent epithelial closure becomes sensitive to H2O2 in flies lacking
MBF1
. We conclude that by preserving the redox-sensitive AP-1 activity,
MBF1
provides an advantage during oxidative stress.
...
PMID:Coactivator MBF1 preserves the redox-dependent AP-1 activity during oxidative stress in Drosophila. 1530 51